HIV protease inhibitor Atazanavir, Purity ≥98%

Cat. No.: X24-06-ZQ887

HIV protease inhibitor Atazanavir, Purity ≥98%

Synonym: 198904-31-3; HIV protease inhibitor; Reyataz; BMS232632

  • MDL: MFCD08435966
  • CAS Number: 198904-31-3
  • Compound CID: 148192
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Atazanavir, soluble in DMSO and ethanol and insoluble in water, blocks the protease enzyme, essential for the maturation and replication of HIV, playing a key role in highly active antiretroviral therapy (HAART). It targets HIV-protease.
Molecular Weight
704.9
Molecular Formula
C38H52N6O7
Targets
HIV-protease
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 62 mg/mL (87.95 mM); Water: Insoluble; Ethanol: 28 mg/mL (39.72 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Atazanavir is employed in the treatment and study of HIV infections by specifically targeting and inhibiting the viral protease enzyme crucial for viral maturation.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0